Postantibiotic effect of colistin alone and combined with vancomycin or meropenem against Acinetobacter spp. with well defined resistance mechanisms

Journal of Chemotherapy
Branka BedenićJasmina Vraneš

Abstract

Previous studies found short postantibiotic effect of colistin on Acinetobacter baumannii. Many studies have evaluated the potential for synergy between colistin and other antibiotics against A. baumannii. The aim of this study was to determine in vitro synergy and postantibiotic effect (PAE) of colistin alone and combined with other antibiotics (vancomycin or meropenem) against eight carbapenem-non-susceptible Acinetobacter spp. strains with defined resistance mechanisms. It was hypothesised that vancomycin or meropenem would prologue the PAE of colistin since it was previously found that they exert synergism with colistin in time-kill kinetics and chequerboard analysis. After exposure of 1 hour colistin alone exhibited the negative ( - 0.07 hour) (OXA-143), short (0.2-1.82 hours) (OXA-24, OXA-58, OXA-72, VIM-1+OXA-23, OXA-58+NDM-1, ISAba1/OXA-69) or moderate PAE (3.2 hours) for OXA-23 positive strain. When combined with vancomycin, the PAE was moderate (1.7-4 hours) with OXA-23, OXA-23+VIM-1, OXA-72 and OXA-24 positive strains while with OXA-58, OXA-143, OXA-58/NDM-1 and ISAba1/OXA-69 positive strains, it was not possible to calculate mean duration of PAE because there was no regrowth after exposure to antibiotics or it was l...Continue Reading

References

Oct 1, 1991·Annals of Emergency Medicine
Jan 1, 1981·Reviews of Infectious Diseases·R W BundtzenW A Craig
Apr 1, 1996·Clinical Microbiology Reviews·E Bergogne-Bérézin, K J Towner
Mar 27, 1999·Lancet·G CornagliaG M Rossolini
Oct 3, 2001·The Journal of Antimicrobial Chemotherapy·H H Haukland, L H Vorland
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthew E Falagas, Sofia K Kasiakou
Dec 8, 2005·The Journal of Antimicrobial Chemotherapy·Susan Brown, Sebastian Amyes
Aug 3, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L Poirel, P Nordmann
Aug 31, 2006·Antimicrobial Agents and Chemotherapy·Jian LiLisa Liolios
Dec 26, 2006·Diagnostic Microbiology and Infectious Disease·Diamantis PlachourasHelen Giamarellou
Feb 10, 2007·The Journal of Antimicrobial Chemotherapy·Roxanne J OwenDenis Spelman
Nov 17, 2007·Nature Reviews. Microbiology·Lenie DijkshoornHarald Seifert
Oct 11, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N PetrosilloM E Falagas
Dec 10, 2008·Antimicrobial Agents and Chemotherapy·G A Pankuch, P C Appelbaum
Dec 10, 2009·The Journal of Antimicrobial Chemotherapy·Paul G HigginsHarald Seifert
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Jennifer H MoffattJohn D Boyce
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Oct 19, 2011·IUBMB Life·Paolo ViscaKevin J Towner
Feb 21, 2013·Antimicrobial Agents and Chemotherapy·Jessica A O'HaraYohei Doi
Aug 7, 2013·Antimicrobial Agents and Chemotherapy·Oren ZusmanMical Paul
Nov 8, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M Vranić-LadavacP Visca
Nov 28, 2013·Antimicrobial Agents and Chemotherapy·Nicola PetrosilloMurat Akova
Jul 22, 2014·Future Microbiology·Emanuele Durante-MangoniRaffaele Zarrilli
Oct 15, 2014·Antimicrobial Agents and Chemotherapy·Kevin S AkersKevin K Chung
Dec 4, 2014·International Journal of Antimicrobial Agents·Wentao NiYouning Liu
Dec 6, 2014·Critical Care : the Official Journal of the Critical Care Forum·João Pedro BaptistaJorge Pimentel
Jan 20, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Branka BedenićGernot Zarfel
May 1, 2015·Chemotherapy·Zrinka BošnjakBranka Bedenić

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

© 2021 Meta ULC. All rights reserved